[1] Martin JY,Schwartz Z,Hummert TW,et al.Effect of titanium surface roughness on proliferation, differentiation, and protein synthesis of human osteoblast-like cells(MG63).J Biomed Mater Res.1995; 29(3): 389-401.[2] Fini M,Cigada A,Rondelli G,et al.In vitro and in vivo behaviour of Ca- and P-enriched anodized titanium.Biomaterials.1999;20(17):1587-1594.[3] Sugino A Ohtsuki C,Tsuru K,et al.Effect of spatial design and thermal oxidation on apatite formation on Ti-15Zr-4Ta-4Nb alloy.Acta Biomater. 2009;5(1):298-304.[4] Kasuga T,Nogami M,Niinomi M,et al.Bioactive calcium phosphate invert glass-ceramic coating on beta-type Ti-29Nb-13Ta-4.6Zr alloy. Biomaterials.2003;24(2):283-290.[5] Yan YY,Han Y.Structure and bioactivity of micro-arc oxidized zirconia films.Surf Coat Techno.2007;201(9-11):5692-5695.[6] Wang G,Meng F,Ding C,et al.Microstructure, bioactivity and osteoblast behavior of monoclinic zirconia coating with nanostructured surface. Acta Biomater.2010;6(3):990-1000.[7] Sollazzo V,Pezzetti F,Scarano A,et al.Zirconium oxide coating improves implant osseointegration in vivo.Dent Mater.2008;24(3):357-361.[8] Zhang S,Sun J,Xu Y,et al.Biological behavior of osteoblast-like cells on titania and zirconia films deposited by cathodic arc deposition. Biointerphases.2012;7(1-4):60.[9] Zhang S,Sun J,Xu Y,et al.Adhesion, proliferation and differentiation of osteoblasts on zirconia films prepared by cathodic arc deposition. Biomed Mater Eng.2013;23(5):373-385.[10] Thian ES,Huang J,Best SM,et al.Magnetron co-sputtered silicon-containing hydroxyapatite thin films--an in vitro study. Biomaterials. 2005;26(16):2947- 2956.[11] Thian ES,Huang J,Best SM,et al.Silicon-substituted hydroxyapatite thin films: effect of annealing temperature on coating stability and bioactivity.J Biomed Mater Res A.2006;78(1):121-128.[12] Thian ES,Huang J,Best SM,et al.A new way of incorporating silicon in hydroxyapatite (Si-HA) as thin films.J Mater Sci Mater Med. 2005; 16(5):411-415.[13] Liu XY,Huang AP,Ding CX,et al.Bioactivity and cytocompatibility of zirconia (ZrO2) films fabricated by cathodic arc deposition.Biomaterials. 2006;27(21):3904-3911.[14] Hench LL.Bioactive materials: the potential for tissue regeneration.J Biomed Mater Res.1998;41(4):511-518.[15] Buser D,Nydegger T,Oxland T,et al.Interface shear strength of titanium implants with a sandblasted and acid-etched surface: a biomechanical study in the maxilla of miniature pigs.J Biomed Mater Res. 1999;45(2): 75-83.[16] Jing W,Zhang M,Jin L,et al.Assessment of osteoinduction using a porous hydroxyapatite coating prepared by micro-arc oxidation on a new titanium alloy.Int J Surg.2015;24(Pt A):51-56.[17] Lynn AK,Duquesnay DL.Hydroxyapatite-coated Ti-6Al-4V Part 2: the effects of post-deposition heat treatment at low temperatures. Biomaterials.2002;23(9):1947-1953.[18] Suchanek W,Yoshimura M.Processing and properties of hydroxyapatite-based biomaterials for use as hard tissue replacement implants.J Mater Res.1998;13(1):94-117.[19] Yang YC,Chang E,Lee SY.Mechanical properties and Young's modulus of plasma-sprayed hydroxyapatite coating on Ti substrate in simulated body fluid.J Biomed Mater Res A.2003;67(3):886-899.[20] 章筛林,成翔宇,纪斌.硅在生物材料领域的应用:增加材料生物活性不影响其机械性能[J].中国组织工程研究,2017,21(2):296-301.[21] Carlisle EM.Silicon: a possible factor in bone calcification.Science. 1970;167(916):279-280.[22] Schwarz K,Milne DB.Growth-promoting effects of silicon in rats.Nature. 1972;239(5371):333-334.[23] Xynos ID,Edgar AJ,Buttery LD,et al.Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun.2000;276(2):461-465.[24] Darley WM,Volcani BE.Role of silicon in diatom metabolism. A silicon requirement for deoxyribonucleic acid synthesis in the diatom Cylindrotheca fusiformis Reimann and Lewin.Exp Cell Res. 1969;58(2): 334-342.[25] Keeting PE,Oursler MJ,Wiegand KE,et al.Zeolite A increases proliferation, differentiation, and transforming growth factor beta production in normal adult human osteoblast-like cells in vitro. J Bone Miner Res.1992;7(11):1281-1289.[26] Reffitt DM,Ogston N,Jugdaohsingh R,et al.Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro.Bone.2003;32(2):127-135.[27] Arumugam MQ,Ireland DC,Brooks RA,et al.The effect orthosilicic acid on collagen type I, alkaline phosphatase and osteocalcin mRNA expression in human bone-derived osteoblasts in vitro.Key Eng Mater. 2006;309-311:121-124.[28] Shepherd JH,Shepherd DV,Best SM.Substituted hydroxyapatites for bone repair.J Mater Sci Mater Med.2012;23(10):2335-2347.[29] Hu HJ,Liu XY,Ding CX.Preparation and cytocompatibility of Si-incorporated nanostructured TiO2 coating.Surf Coat Technol. 2010;204(20):3265-3271.[30] Zhang Z,Sun J,Hu H,et al.Osteoblast-like cell adhesion on porous silicon-incorporated TiO2 coating prepared by micro-arc oxidation.J Biomed Mater Res B Appl Biomater.2011;97(2):224-234.[31] Matsuo K,Irie N.Osteoclast-osteoblast communication.Arch Biochem Biophys.2008;473(2):201-209.[32] Boyle WJ,Lacey DL,Timms E,et al.Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.Cell.1998;93(2):165-176.[33] Roodman GD.Advances in bone biology: the osteoclast.Endocr Rev. 1996;17(4):308-332.[34] Suda T,Nakamura I,Jimi E,et al.Regulation of osteoclast function.J Bone Miner Res.1997;12(6):869-879.[35] Suda T,Udagawa N,Nakamura I,et al.Modulation of osteoclast differentiation by local factors. Bone.1995;17(2 Suppl):87S-91S.[36] Hofbauer LC,Heufelder AE.Clinical review 114: hot topic. The role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases.J Clin Endocrinol Metab.2000;85(7):2355-2363.[37] Hofbauer LC,Khosla S,Dunstan CR,et al.The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.J Bone Miner Res.2000;15(1):2-12.[38] Hsu H,Lacey DL,Dunstan CR,et al.Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.Proc Natl Acad Sci U S A.1999;96(7):3540-3545.[39] Kulkarni RN,Bakker AD,Everts V,et al.Inhibition of osteoclastogenesis by mechanically loaded osteocytes: involvement of MEPE.Calcif Tissue Int.2010;87(5):461-468.[40] 黎彦龙,明何,陈秉雄,等.OPG-RANKL-RANK信号系统是调节破骨细胞及骨质疏松症的重要途径[J].中国组织工程研究,2015,19(24):3894-3898. |